Concurrently with a robust destruction to primary melanoma, CAH‐mediated PDT treatment elicits durable and systemic immunological effects to combat metastases and recurring tumors depending on the activation of CD4+CD8+ double positive T cells. Here, CD4 is linked to melanoma.